| Literature DB >> 32211956 |
S J van Ommeren-Olijve1, J P M Burbach2, E J B Furnée3.
Abstract
PURPOSE: A substantial part (21-35%) of defunctioning stomas created during resection for colorectal cancer will never be reversed. Known risk factors for non-closure are age, peri- or postoperative complications, comorbidity, and tumor stage. However, studies performed to identify these risk factors mostly focus on rectal cancer and include both preoperative and postoperative factors. This study aims to identify preoperative risk factors for non-reversal of intended temporary stomas created during acute resection of left-sided obstructive colon cancer (LSOCC) with primary anastomosis.Entities:
Keywords: Colorectal cancer; Defunctioning stoma; Non-closure; Obstructive colon cancer; Stoma reversal; Surgical oncology
Mesh:
Substances:
Year: 2020 PMID: 32211956 PMCID: PMC7245586 DOI: 10.1007/s00384-020-03559-1
Source DB: PubMed Journal: Int J Colorectal Dis ISSN: 0179-1958 Impact factor: 2.571
Fig. 1Flow-chart of patient inclusion
Baseline characteristics
| Stoma closure | No stoma closure | |
|---|---|---|
| Male | 53 (51.0%) | 29 (56.9%) |
| Female | 51 (49.0%) | 22 (43.1%) |
| Age (years) | ||
| −50 | 3 (2.9%) | 5 (9.8%) |
| 50–60 | 22 (21.2%) | 6 (11.8%) |
| 60–70 | 35 (33.7%) | 16 (31.4%) |
| 70–80 | 34 (32.7%) | 13 (25.5%) |
| 80+ | 10 (9.6%) | 11 (21.6%) |
| BMI (kg/m2) | 25 (17–38) | 24 (18–40) |
| BMI ≤ 30 | 80 (85.1%) | 39 (83.0%) |
| BMI > 30 | 14 (14.9%) | 8 (17.0%) |
| ASA-classification | ||
| ASA 1–2 | 81 (77.9%) | 33 (64.7%) |
| ASA 3–5 | 23 (22.1%) | 18 (35.3%) |
| Duration of symptoms prior to presentation (days) | 6 (0–173) | 5 (0–154) |
| Preoperative hemoglobin (mmol/L) | 8.8 (4.7–11.7) | 8.5 (5.2–11.4) |
| Preoperative leukocyte count (× 109/L) | 11.4 (4.1–27.2) | 11.1 (4.7–24.0) |
| Preoperative C-reactive protein (mg/L) | 10 (1–239) | 22 (1–290) |
| Preoperative eGFR (mL/min/1.73 m2) | 83 (32–154) | 76 (12–130) |
| Clinical M-stage | ||
| cM0 | 92 (91.1%) | 32 (64.0%) |
| cM1 | 9 (8.9%) | 18 (36.0%) |
| Type of resection | ||
| Sigmoidectomy | 61 (58.7%) | 26 (51.0%) |
| Left hemicolectomy | 20 (19.2%) | 11 (21.6%) |
| Subtotal colectomy | 2 (1.9%) | 3 (5.9%) |
| Low anterior resection (partial mesorectal excision) | 18 (17.3%) | 6 (11.8%) |
| Sigmoidectomy + right hemicolectomy | 3 (2.9%) | 4 (7.8%) |
| Transverse colon resection | 0 (0.0%) | 1 (2.0%) |
| Approach of operation | ||
| Open | 92 (88.5%) | 51 (100.0%) |
| Laparoscopic | 12 (11.5%) | 0 (0.0%) |
| Stoma location | ||
| Ileum | 80 (76.9%) | 37 (72.5%) |
| Ascending colon | 1 (1.0%) | 3 (5.9%) |
| Transverse colon | 21 (20.2%) | 7 (13.7%) |
| Descending colon | 2 (1.9%) | 4 (7.8%) |
| Pathological tumor stage | ||
| pT2 | 3 (2.9%) | 0 (0.0%) |
| pT3 | 74 (71.2%) | 34 (66.7%) |
| pT4 | 27 (26.0%) | 17 (33.3%) |
| pN0 | 48 (46.2%) | 17 (33.3%) |
| pN1 | 34 (32.7%) | 19 (37.3%) |
| pN2 | 22 (21.2%) | 15 (29.4%) |
Data are given as number of cases (%). Continuous variables were given as median (range)
BMI, body mass index; ASA, American Society of Anesthesiologists; eGFR, estimated glomerular filtration rate
Univariable and multivariable analysis
| Univariable analysis OR (95% CI) | Multivariable analysis OR (95% CI) | |||
|---|---|---|---|---|
| Age (years) | 0.576 | |||
| ≤ 70 | 1.00 (reference) | |||
| > 70 | 1.21 (0.62–2.38) | |||
| Sex | 0.490 | |||
| Male | 1.00 (reference) | |||
| Female | 0.79 (0.40–1.55) | |||
| BMI (kg/m2) | 0.99 (0.91–1.07) | 0.783 | ||
| ASA-classification | 0.083 | |||
| ASA 1–2 | 1.00 (reference) | |||
| ASA 3–5 | 1.92 (0.92–4.02) | |||
| Duration of symptoms prior to presentation (days) | 1.01 (0.99–1.02)a | 0.319 | ||
| Preoperative hemoglobin | ||||
| > 7.5 mmol/L | 1.00 (reference) | 1.00 (reference) | ||
| < 7.5 mmol/L | 2.96 (1.14–7.72) | 4.79 (1.60–14.38) | ||
| Preoperative leukocyte count (× 109/L) | 0.99 (0.91–1.07) | 0.736 | ||
| Preoperative C-reactive protein | ||||
| ≤ 10 mg/L | 1.00 (reference) | |||
| > 10 mg/L | 2.53 (1.28–5.31) | |||
| Preoperative eGFR | ||||
| > 45 mL/min/1.73 m2 | 1.00 (reference) | 1.00 (reference) | ||
| ≤ 45 mL/min/1.73 m2 | 3.62 (1.21–10.84) | 4.64 (1.41–15.10) | ||
| Clinical M-stage | ||||
| cM0 | 1.00 (reference) | 1.00 (reference) | ||
| cM1 | 5.75 (2.35–14.08) | 6.12 (2.35–15.94) | ||
| Type of stoma | 0.597 | |||
| Ileostoma | 1.00 (reference) | |||
| Colostoma | 1.23 (0.57–2.65) | |||
OR (95% CI), odds ratio (95% confidence interval); BMI, body mass index; eGFR, estimated glomerular filtration rate; NS, not significant; ASA, American Society of Anesthesiologists
The significant p-values in uni- and multivariable analysis are highlighted in italic